12:00 AM
 | 
Jan 12, 2015
 |  BC Week In Review  |  Clinical News  |  Regulatory

Carmeseal-MD regulatory update

Phrixus and Ethicor Pharma Ltd. (London, U.K.) will begin a European access program this month to provide Carmeseal-MD to treat...

Read the full 88 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >